{"slug":"quality-of-life","tag":"quality-of-life","variants":["quality-of-life"],"description":"No description yet","count":2,"kinds":{"person":1,"technology":1},"related":[{"slug":"clinician-scientist","tag":"clinician-scientist","shared":1},{"slug":"leadership","tag":"leadership","shared":1},{"slug":"patient-reported-outcomes","tag":"patient-reported-outcomes","shared":1},{"slug":"psychosocial","tag":"psychosocial","shared":1},{"slug":"rejuvenation","tag":"rejuvenation","shared":1},{"slug":"survivorship","tag":"survivorship","shared":1},{"slug":"transplant","tag":"transplant","shared":1}],"records":[{"id":"sandra-nolte","kind":"person","name":"Sandra Nolte","route":"/people/sandra-nolte/","tldr":"Monash University researcher who is President of the international society for health-related quality of life research for the 2025 to 2027 term."},{"id":"rejuv-tx-quality-of-life","kind":"technology","name":"Quality of life after transplant and cell therapy","route":"/technologies/rejuv-tx-quality-of-life/","status":"established","tldr":"Most people who come through a transplant or CAR-T report, years later, a quality of life close to that of people who never had one. Underneath that, a substantial minority live with fatigue, anxiety, low mood or trouble concentrating, and the strongest predictor is having had anxiety or depression before treatment, which is treatable."}]}